文献速递淋巴瘤

靶向深度测序揭示成人T细胞白血病/淋巴瘤的克隆与亚克隆突变特征并定义一种预后不良的惰性亚型

Targeted deep sequencing reveals clonal and subclonal mutational signatures in Adult T-cell leukemia/lymphoma and defines an unfavorable indolent subtype.
PubMed 文献 · Leukemia · 2020-06-17

本研究对61例非洲和加勒比裔成人T细胞白血病/淋巴瘤(ATL)患者行靶向深度测序并定位HTLV-1前病毒整合位点,发现突变主要累及TCR/NF-kB、T细胞运输、免疫逃逸和细胞周期通路;纵向分析显示复发或进展患者存在克隆演化,惰性亚型中TCR/NF-kB通路突变(克隆或亚克隆)与显著缩短的进展时间和总生存相关。

要点

  • 61例非洲和加勒比裔ATL患者中,突变主要累及TCR/NF-kB(74%)、T细胞运输(46%)、免疫逃逸(29%)和细胞周期(26%)通路。
  • 惰性亚型中TCR/NF-kB通路突变(无论克隆或亚克隆)与显著缩短的进展时间和总生存相关。
  • 进展患者纵向分析发现诊断时亚克隆水平(等位基因频率<5%)的NF-kB/NFAT突变在进展时出现。

核心结论

  • 研究揭示了ATL复发和进展过程中突变特征的克隆动力学,并定义了一个以高转化风险突变特征为特点的惰性ATL新亚组。

研究设计与样本

  • 对61例非洲和加勒比裔ATL患者行靶向深度测序并结合HTLV-1前病毒整合位点定位。
  • 对复发或从惰性进展为侵袭性亚型的患者进行纵向研究。

主要发现

  • 突变主要影响TCR/NF-kB(74%)、T细胞运输(46%)、免疫逃逸(29%)和细胞周期(26%)相关通路,与日本大型队列先前报道的基因组 Landscape 一致。
  • 复发患者的系列分析识别出几种克隆演化模式。
  • 进展患者的纵向研究显示,进展时出现的NF-kB/NFAT突变在诊断时以亚克隆水平存在(等位基因频率<5%)。
  • 惰性亚型中TCR/NF-kB通路突变(无论克隆或亚克隆)与显著缩短的进展时间和总生存相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Adult T-cell leukemia/lymphoma (ATL) carries a poor prognosis even in indolent subtypes. We performed targeted deep sequencing combined with mapping of HTLV-1 proviral integration sites of 61 ATL patients of African and Caribbean origin. This revealed mutations mainly affecting TCR/NF-kB (74%), T-cell trafficking (46%), immune escape (29%), and cell cycle (26%) related pathways, consistent with the genomic landscape previously reported in a large Japanese cohort. To examine the evolution of mutational signatures upon disease progression while tracking the viral integration architecture of the malignant clone, we carried out a longitudinal study of patients who either relapsed or progressed from an indolent to an aggressive subtype. Serial analysis of relapsing patients identified several patterns of clonal evolution. In progressing patients, the longitudinal study revealed NF-kB/NFAT mutations at progression that were present at a subclonal level at diagnosis (allelic frequency < 5%). Moreover, the presence in indolent subtypes of mutations affecting the TCR/NF-kB pathway, whether clonal or subclonal, was associated with significantly shorter time to progression and overall survival. Our observations reveal the clonal dynamics of ATL mutational signatures at relapse and during progression. Our study defines a new subgroup of indolent ATLs characterized by a mutational signature at high risk of transformation.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Marçais A, Lhermitte L, Artesi M, et al. Targeted deep sequencing reveals clonal and subclonal mutational signatures in Adult T-cell leukemia/lymphoma and defines an unfavorable indolent subtype. Leukemia. 2020. PMID: 32555298. doi:10.1038/s41375-020-0900-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。